Global and United States Dydrogesterone Drug Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

Market Analysis and Insights: Global and United States Dydrogesterone Drug Market

This report focuses on global and United States Dydrogesterone Drug market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Dydrogesterone Drug market size is estimated to be worth US$ 658.2 million in 2022 and is forecast to a readjusted size of US$ 1147 million by 2028 with a CAGR of 9.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Dydrogesterone accounting for % of the Dydrogesterone Drug global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Infertility was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

The classification of Dydrogesterone Drug includes Dydrogesterone and Dydrogesterone +Estradiol Compound, and the sale proportion of dydrogesterone is about 75.22%.

Dydrogesterone Drug is widely used for Infertility, Gynecological Diseases, Threatened Abortion, etc. The most proportion of Dydrogesterone Drug is used for Infertility, and the proportion is 67.71%.

There are mainly two manufacturers in this industry, which is Abbott and Viatris，and their production are in Europe and USA respectively.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 62.27%. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 15.77%.

Global Dydrogesterone Drug Scope and Market Size
Dydrogesterone Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Dydrogesterone Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Dydrogesterone Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Dydrogesterone
    Dydrogesterone+Estradiol Compound

Segment by Application
    Infertility
    Gynecological Diseases
    Threatened Abortion
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Abbott
    Viatris

 1 Study Coverage
    1.1 Dydrogesterone Drug Product Introduction
    1.2 Global Dydrogesterone Drug Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Dydrogesterone Drug Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Dydrogesterone Drug Sales in Volume for the Year 2017-2028
    1.3 United States Dydrogesterone Drug Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Dydrogesterone Drug Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Dydrogesterone Drug Sales in Volume for the Year 2017-2028
    1.4 Dydrogesterone Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Dydrogesterone Drug in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Dydrogesterone Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Dydrogesterone Drug Market Dynamics
        1.5.1 Dydrogesterone Drug Industry Trends
        1.5.2 Dydrogesterone Drug Market Drivers
        1.5.3 Dydrogesterone Drug Market Challenges
        1.5.4 Dydrogesterone Drug Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Dydrogesterone Drug Market Segment by Type
        2.1.1 Dydrogesterone
        2.1.2 Dydrogesterone+Estradiol Compound
    2.2 Global Dydrogesterone Drug Market Size by Type
        2.2.1 Global Dydrogesterone Drug Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Dydrogesterone Drug Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Dydrogesterone Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Dydrogesterone Drug Market Size by Type
        2.3.1 United States Dydrogesterone Drug Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Dydrogesterone Drug Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Dydrogesterone Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Dydrogesterone Drug Market Segment by Application
        3.1.1 Infertility
        3.1.2 Gynecological Diseases
        3.1.3 Threatened Abortion
        3.1.4 Other
    3.2 Global Dydrogesterone Drug Market Size by Application
        3.2.1 Global Dydrogesterone Drug Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Dydrogesterone Drug Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Dydrogesterone Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Dydrogesterone Drug Market Size by Application
        3.3.1 United States Dydrogesterone Drug Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Dydrogesterone Drug Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Dydrogesterone Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Dydrogesterone Drug Competitor Landscape by Company
    4.1 Global Dydrogesterone Drug Market Size by Company
        4.1.1 Top Global Dydrogesterone Drug Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Dydrogesterone Drug Revenue by Manufacturer (2017-2022)
        4.1.3 Global Dydrogesterone Drug Sales by Manufacturer (2017-2022)
        4.1.4 Global Dydrogesterone Drug Price by Manufacturer (2017-2022)
    4.2 Global Dydrogesterone Drug Concentration Ratio (CR)
        4.2.1 Dydrogesterone Drug Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dydrogesterone Drug in 2021
        4.2.3 Global Dydrogesterone Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Dydrogesterone Drug Manufacturing Base Distribution, Product Type
        4.3.1 Global Dydrogesterone Drug Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Dydrogesterone Drug Product Type
        4.3.3 Date of International Manufacturers Enter into Dydrogesterone Drug Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Dydrogesterone Drug Market Size by Company
        4.5.1 Top Dydrogesterone Drug Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Dydrogesterone Drug Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Dydrogesterone Drug Sales by Players (2020, 2021 & 2022)

 5 Global Dydrogesterone Drug Market Size by Region
    5.1 Global Dydrogesterone Drug Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Dydrogesterone Drug Market Size in Volume by Region (2017-2028)
        5.2.1 Global Dydrogesterone Drug Sales in Volume by Region: 2017-2022
        5.2.2 Global Dydrogesterone Drug Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Dydrogesterone Drug Market Size in Value by Region (2017-2028)
        5.3.1 Global Dydrogesterone Drug Sales in Value by Region: 2017-2022
        5.3.2 Global Dydrogesterone Drug Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Dydrogesterone Drug Market Size YoY Growth 2017-2028
        6.1.2 North America Dydrogesterone Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Dydrogesterone Drug Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Dydrogesterone Drug Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Dydrogesterone Drug Market Size YoY Growth 2017-2028
        6.3.2 Europe Dydrogesterone Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Dydrogesterone Drug Market Size YoY Growth 2017-2028
        6.4.2 Latin America Dydrogesterone Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Dydrogesterone Drug Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Dydrogesterone Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Corporation Information
        7.1.2 Abbott Description and Business Overview
        7.1.3 Abbott Dydrogesterone Drug Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Abbott Dydrogesterone Drug Products Offered
        7.1.5 Abbott Recent Development
    7.2 Viatris
        7.2.1 Viatris Corporation Information
        7.2.2 Viatris Description and Business Overview
        7.2.3 Viatris Dydrogesterone Drug Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Viatris Dydrogesterone Drug Products Offered
        7.2.5 Viatris Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Dydrogesterone Drug Industry Chain Analysis
    8.2 Dydrogesterone Drug Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Dydrogesterone Drug Distributors
    8.3 Dydrogesterone Drug Production Mode & Process
    8.4 Dydrogesterone Drug Sales and Marketing
        8.4.1 Dydrogesterone Drug Sales Channels
        8.4.2 Dydrogesterone Drug Distributors
    8.5 Dydrogesterone Drug Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Dydrogesterone Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Dydrogesterone Drug Market Trends
    Table 3. Dydrogesterone Drug Market Drivers
    Table 4. Dydrogesterone Drug Market Challenges
    Table 5. Dydrogesterone Drug Market Restraints
    Table 6. Global Dydrogesterone Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Dydrogesterone Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Dydrogesterone Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Dydrogesterone Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Dydrogesterone Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Dydrogesterone Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Dydrogesterone Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Dydrogesterone Drug Sales by Manufacturer, (M Pills), 2017-2022
    Table 14. Global Dydrogesterone Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Dydrogesterone Drug Price by Manufacturer (2017-2022) & (USD/Pill)
    Table 16. Global Dydrogesterone Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dydrogesterone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dydrogesterone Drug as of 2021)
    Table 18. Top Players of Dydrogesterone Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Dydrogesterone Drug Product Type
    Table 20. Date of International Manufacturers Enter into Dydrogesterone Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Dydrogesterone Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Dydrogesterone Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Dydrogesterone Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Dydrogesterone Drug Sales by Players, (M Pills), 2020, 2021 & 2022
    Table 26. United States Dydrogesterone Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Dydrogesterone Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Dydrogesterone Drug Sales in Volume by Region (2017-2022) & (M Pills)
    Table 29. Global Dydrogesterone Drug Sales in Volume Forecast by Region (2023-2028) & (M Pills)
    Table 30. Global Dydrogesterone Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Dydrogesterone Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Dydrogesterone Drug Sales in Volume by Country (2017-2028) & (M Pills)
    Table 33. North America Dydrogesterone Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Dydrogesterone Drug Sales in Volume by Region (2017-2028) & (M Pills)
    Table 35. Asia Pacific Dydrogesterone Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Dydrogesterone Drug Sales in Volume by Country (2017-2028) & (M Pills)
    Table 37. Europe Dydrogesterone Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Dydrogesterone Drug Sales in Volume by Country (2017-2028) & (M Pills)
    Table 39. Latin Americaa Dydrogesterone Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Dydrogesterone Drug Sales in Volume by Country (2017-2028) & (M Pills)
    Table 41. Middle East and Africa Dydrogesterone Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abbott Corporation Information
    Table 43. Abbott Description and Business Overview
    Table 44. Abbott Dydrogesterone Drug Sales (M Pills), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 45. Abbott Dydrogesterone Drug Product
    Table 46. Abbott Recent Development
    Table 47. Viatris Corporation Information
    Table 48. Viatris Description and Business Overview
    Table 49. Viatris Dydrogesterone Drug Sales (M Pills), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022)
    Table 50. Viatris Product
    Table 51. Viatris Recent Development
    Table 52. Key Raw Materials Lists
    Table 53. Raw Materials Key Suppliers Lists
    Table 54. Dydrogesterone Drug Customers List
    Table 55. Dydrogesterone Drug Distributors List
    Table 56. Research Programs/Design for This Report
    Table 57. Key Data Information from Secondary Sources
    Table 58. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dydrogesterone Drug Product Picture
    Figure 2. Global Dydrogesterone Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Dydrogesterone Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Dydrogesterone Drug Sales 2017-2028 (M Pills)
    Figure 5. United States Dydrogesterone Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Dydrogesterone Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Dydrogesterone Drug Sales 2017-2028 (M Pills)
    Figure 8. United States Dydrogesterone Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Dydrogesterone Drug Market Share in Global, in Volume (M Pills) 2017-2028
    Figure 10. Dydrogesterone Drug Report Years Considered
    Figure 11. Product Picture of Dydrogesterone
    Figure 12. Product Picture of Dydrogesterone+Estradiol Compound
    Figure 13. Global Dydrogesterone Drug Market Share by Type in 2022 & 2028
    Figure 14. Global Dydrogesterone Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Dydrogesterone Drug Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Dydrogesterone Drug Sales by Type (2017-2028) & (M Pills)
    Figure 17. Global Dydrogesterone Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Dydrogesterone Drug Price by Type (2017-2028) & (USD/Pill)
    Figure 19. United States Dydrogesterone Drug Market Share by Type in 2022 & 2028
    Figure 20. United States Dydrogesterone Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Dydrogesterone Drug Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Dydrogesterone Drug Sales by Type (2017-2028) & (M Pills)
    Figure 23. United States Dydrogesterone Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Dydrogesterone Drug Price by Type (2017-2028) & (USD/Pill)
    Figure 25. Product Picture of Infertility
    Figure 26. Product Picture of Gynecological Diseases
    Figure 27. Product Picture of Threatened Abortion
    Figure 28. Product Picture of Other
    Figure 29. Global Dydrogesterone Drug Market Share by Application in 2022 & 2028
    Figure 30. Global Dydrogesterone Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Dydrogesterone Drug Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Dydrogesterone Drug Sales by Application (2017-2028) & (M Pills)
    Figure 33. Global Dydrogesterone Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Dydrogesterone Drug Price by Application (2017-2028) & (USD/Pill)
    Figure 35. United States Dydrogesterone Drug Market Share by Application in 2022 & 2028
    Figure 36. United States Dydrogesterone Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Dydrogesterone Drug Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Dydrogesterone Drug Sales by Application (2017-2028) & (M Pills)
    Figure 39. United States Dydrogesterone Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Dydrogesterone Drug Price by Application (2017-2028) & (USD/Pill)
    Figure 41. North America Dydrogesterone Drug Sales in Volume Growth Rate 2017-2028 (M Pills)
    Figure 42. North America Dydrogesterone Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Dydrogesterone Drug Sales in Volume Growth Rate 2017-2028 (M Pills)
    Figure 46. Europe Dydrogesterone Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Dydrogesterone Drug Sales in Volume Growth Rate 2017-2028 (M Pills)
    Figure 53. Asia-Pacific Dydrogesterone Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. China Taiwan Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Dydrogesterone Drug Sales in Volume Growth Rate 2017-2028 (M Pills)
    Figure 64. Latin America Dydrogesterone Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Dydrogesterone Drug Sales in Volume Growth Rate 2017-2028 (M Pills)
    Figure 69. Middle East & Africa Dydrogesterone Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Dydrogesterone Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Dydrogesterone Drug Value Chain
    Figure 74. Dydrogesterone Drug Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed

Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.

Market Analysis and Insights: Global and United States Dydrogesterone Drug Market

This report focuses on global and United States Dydrogesterone Drug market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Dydrogesterone Drug market size is estimated to be worth US$ 658.2 million in 2022 and is forecast to a readjusted size of US$ 1147 million by 2028 with a CAGR of 9.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Dydrogesterone accounting for % of the Dydrogesterone Drug global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Infertility was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

The classification of Dydrogesterone Drug includes Dydrogesterone and Dydrogesterone +Estradiol Compound, and the sale proportion of dydrogesterone is about 75.22%.

Dydrogesterone Drug is widely used for Infertility, Gynecological Diseases, Threatened Abortion, etc. The most proportion of Dydrogesterone Drug is used for Infertility, and the proportion is 67.71%.

There are mainly two manufacturers in this industry, which is Abbott and Viatris，and their production are in Europe and USA respectively.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 62.27%. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 15.77%.

Global Dydrogesterone Drug Scope and Market Size
Dydrogesterone Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Dydrogesterone Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Dydrogesterone Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Dydrogesterone
    Dydrogesterone+Estradiol Compound

Segment by Application
    Infertility
    Gynecological Diseases
    Threatened Abortion
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Abbott
    Viatris